Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Debt (2021 - 2024)

Roivant Sciences' Total Debt history spans 4 years, with the latest figure at $49.8 million for Q2 2024.

  • For Q2 2024, Total Debt fell 37.62% year-over-year to $49.8 million; the TTM value through Jun 2024 reached $49.8 million, down 37.62%, while the annual FY2024 figure was $200.7 million, 0.01% changed from the prior year.
  • Total Debt reached $49.8 million in Q2 2024 per ROIV's latest filing, down from $200.7 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $217.7 million in Q4 2023 to a low of $32.6 million in Q1 2022.
  • Average Total Debt over 4 years is $137.3 million, with a median of $178.3 million recorded in 2021.
  • Peak YoY movement for Total Debt: crashed 82.13% in 2022, then skyrocketed 515.19% in 2023.
  • A 4-year view of Total Debt shows it stood at $204.0 million in 2021, then tumbled by 64.73% to $72.0 million in 2022, then soared by 202.48% to $217.7 million in 2023, then plummeted by 77.12% to $49.8 million in 2024.
  • Per Business Quant, the three most recent readings for ROIV's Total Debt are $49.8 million (Q2 2024), $200.7 million (Q1 2024), and $217.7 million (Q4 2023).